Iman K. Yazdi

Iman K. Yazdi

Auto-generated profile, based on publicly available information

Iman K. Yazdi

Department of Nanomedicine, Houston Methodist Research Institute, Houston, TX 77030, USA

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 December 2012 in Nature Nanotechnology
Verified
Journal Article
Closed access
PDF file
Alessandro ParodiAlessandro Parodi
Alessandro Parodi
NQNicoletta Quattrocchi
Nicoletta Quattrocchi
AVAnne L. van de Ven
Anne L. van de Ven
CCCiro Chiappini
Ciro Chiappini
MEMichael Evangelopoulos
Michael Evangelopoulos
ETEnnio Tasciotti
Ennio Tasciotti

23 May 2016 in Nature Materials
Verified
Journal Article
Open access
PDF file
Roberto MolinaroRoberto Molinaro
Roberto Molinaro
Claudia CorboClaudia Corbo
Claudia Corbo
JMJ. O. Martinez
J. O. Martinez
FTFrancesca Taraballi
Francesca Taraballi
MEMichael Evangelopoulos
Michael Evangelopoulos
ETE. Tasciotti
E. Tasciotti
A multitude of micro- and nanoparticles have been developed to improve the delivery of systemically administered pharmaceuticals, which are subject to a number of biological barriers that limit their optimal biodistribution. Bioinspired drug-delivery carriers formulated by bottom-up or top-down strategies have emerged as an alternative approach to evade the mononuclear phagocytic system and facilitate transport across the endothelial vessel wall. Here, we describe a method that leverages the advantages of bottom-up and top-down strategies to incorporate proteins derived from the leukocyte plasma membrane into lipid nanoparticles. The resulting proteolipid vesicles—which we refer to as leukosomes—retained the versatility and physicochemical properties typical of liposomal formulations, preferentially targeted inflamed vasculature, enabled the selective and effective delivery of dexamethasone to inflamed tissues, and reduced phlogosis in a localized model of inflammation.

6 July 2018 in Small
Verified
Journal Article
Closed access
PDF file
PMPooria Mostafalu
Pooria Mostafalu
Ali TamayolAli Tamayol
Ali Tamayol
RRRahim Rahimi
Rahim Rahimi
MOManuel Ochoa
Manuel Ochoa
AKAkbar Khalilpour
Akbar Khalilpour
Ali  KhademhosseiniAli Khademhosseini
Ali Khademhosseini

1 June 2016 in Sensors and Actuators B: Chemical
Verified
Journal Article
Closed access
RRRahim Rahimi
Rahim Rahimi
MOManuel Ochoa
Manuel Ochoa
TPTejasvi Parupudi
Tejasvi Parupudi
Xin ZhaoXin Zhao
Xin Zhao
IYIman K. Yazdi
Iman K. Yazdi
BZBabak Ziaie
Babak Ziaie

13 August 2014 in ACS Nano
Verified
Journal Article
Open access
Alessandro ParodiAlessandro Parodi
Alessandro Parodi
SHSeth G. Haddix
Seth G. Haddix
NTNima Taghipour
Nima Taghipour
SSShilpa Scaria
Shilpa Scaria
FTFrancesca Taraballi
Francesca Taraballi
ETEnnio Tasciotti
Ennio Tasciotti
Tumor extracellular matrix (ECM) represents a major obstacle to the diffusion of therapeutics and drug delivery systems in cancer parenchyma. This biological barrier limits the efficacy of promising therapeutic approaches including the delivery of siRNA or agents intended for thermoablation. After extravasation due to the enhanced penetration and retention effect of tumor vasculature, typical nanotherapeutics are unable to reach the nonvascularized and anoxic regions deep within cancer parenchyma. Here, we developed a simple method to provide mesoporous silica nanoparticles (MSN) with a proteolytic surface. To this extent, we chose to conjugate MSN to Bromelain (Br–MSN), a crude enzymatic complex, purified from pineapple stems, that belongs to the peptidase papain family. This surface modification increased particle uptake in endothelial, macrophage, and cancer cell lines with minimal impact on cellular viability. Most importantly Br–MSN showed an increased ability to digest and diffuse in tumor ECM in vitro and in vivo.

1 July 2012 in Biomaterials
Verified
Journal Article
Closed access
MMMatthew B. Murphy
Matthew B. Murphy
DBDaniel Blashki
Daniel Blashki
RBRachel M. Buchanan
Rachel M. Buchanan
IYIman K. Yazdi
Iman K. Yazdi
MFMauro Ferrari
Mauro Ferrari
ETEnnio Tasciotti
Ennio Tasciotti